MUFG Securities EMEA’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
EIG
MUFG Securities EMEA's DGX Position: Q2 2026 in Review
MUFG Securities EMEA reduced its Quest Diagnostics (DGX) stake by 4.5% in Q2 2026, selling an estimated $39.6K and leaving 4,308 shares worth $913K. The position accounts for 0.01% of the portfolio, ranked #434.
MUFG Securities EMEA first reported a position in DGX in Q2 2018 and has held it in 17 quarters since. The position peaked at $26.1M in Q4 2020. 1,100 funds tracked by Wall St. Rank hold DGX as of Q2 2026.
- MUFG Securities EMEA held 4,308 shares of Quest Diagnostics worth $913K as of Q2 2026.
- MUFG Securities EMEA sold 202 Quest Diagnostics shares in Q2 2026, an estimated $39.6K.
- Quest Diagnostics made up 0.01% of MUFG Securities EMEA's portfolio in Q2 2026, its #434 holding.
- MUFG Securities EMEA first reported a position in Quest Diagnostics in Q2 2018 and has held it in 17 quarters since.
- MUFG Securities EMEA's Quest Diagnostics position peaked at $26.1M in Q4 2020.
- 1,100 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.
Based on MUFG Securities EMEA's 13F filing for Q2 2026, filed 12 Aug 2026.